Abstract
An acute effect of triazolam, a potent benzodiazepine agonist, on cholinergic receptor binding in the human brain was measured by PET (positron emission tomography) using [11C]N-methyl-4-piperidylbenzilate ([11C]NMPB), a potent muscarinic cholinergic receptor antagonist. Two PET scans were performed in each subject: (1) control scan; (2) after oral administration of 0.5 mg triazolam or placebo. The previously discussed amnestic effect of triazolam was measured by immediate and delayed recall of meaningful and meaningless syllables. A compartment model employing the radioactivity in the cerebellum as an input function was used for the quantification of receptor binding. The binding parameter,k 3, was decreased after triazolam administration in all measured regions, whereas no change was observed after placebo treatment. The reduction compared to the control study varied from 8.6±3.7% in the temporal cortex to 16.3±6.3% in the thalamus. Triazolam administration impaired both immediate and delayed recall of syllables, whereas placebo administration had no effects. Benzodiazepine agonists are reported to decrease the cortical acetylcholine release. The decrease of acetylcholine release in the synaptic cleft might be the explanation for the decreased binding of [11C]NMPB.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bischoff S, Krauss J, Grunenwald C, Gunst F, Heinrich M, Schaub M, Stocklin K, Vassout A, Waldmeier P, Maitre L (1991) Endogenous dopamine (DA) modulates [3H]spiperone binding in vivo in rat brain. J Recept Res 11:163–175
Chugani DC, Ackermann RF, Phelps ME (1988) In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization. J Cereb Blood Flow Metab 8:291–303
Consolo S, Ladinsky H, Peri G, Garattini S (1974) Effect of diazepam on mouse whole brain and brain area acetylcholine and choline levels. Eur J Pharmacol 27:266–268
Curran HV (1991) Benzodiazepines, memory and mood: a review. Psychopharmacology 105:1–8
Decker MW, McGaugh JL (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7:151–168
Dewey SL, Brodie JD, Fowler JS, MacGregor RR, Schlyer DJ, King PT, Alexoff DL, Volkow ND, Shiue C-Y, Wolf AP, Bendrium B (1990) Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain. Synapse 6:321–327
Dewey SL, Logan J, Wolf AP, Brodie JD, Angrist B, Fowler JS, Volkow ND (1991) Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography. Synapse 7:324–327
Dorow R, Berenberg D, Duka T, Sauerbrey N (1987) Amnesic effects of lormetazepam and their reversal by benzodiazepine antagonist Ro 15-1788. Psychopharmacology 93:507–514
Drachman DA, Leavitt J (1974) Human memory and cholinergic system: a relationship to aging? Arch Neurol 30:113–121
Ebbinghaus H (1885) Über das Gedaechtnis. Duncker & Humbolt, Leipzig
Eckernäs S-Å, Aquilonius SM, Hartvig P, Hägglund J, Lundqvist H, Någren K, Långström B (1987) Positron emission tomography (PET) in the study of dopamine receptors in the primate brain: evaluation of a kinetic model using11C-N-methyl-spiperone. Acta Neurol Scand 75:168–178
Endo M, Fukuda H, Suhara T, Matsumoto T, Iinuma T, Yamasaki T, Tateno Y, Nohara N, Ogushi A, Kumamoto M, Inoue S (1991) Design and performance of PCT-3600 W (15-slice type): a whole-body positron emission tomography. J Nucl Med 32:1061
Farde L, Nordström A-L, Wiesel F-A, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatry 49: 538–544
Fazio F, Perani D, Gilardi MC, Colombo F, Cappa SF, Vallar G, Bettinardi V, Paulesu E, Alberoni M, Bressi S, Franceschi M, Lenzi GL (1992) Metabolic impairment in human amnesia: a PET study of memory networks. J Cereb Blood Flow Metab 12:353–358
Frith CD, Richardson JTE, Samuel M, Crow TJ, McKenna PJ (1984) The effects of intravenous diazepam and hyoscine upon human memory. Q J Exp Psychol 36A: 133–144
Ghoneim MM, Mewaldt SP (1975) Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory. Psychopharmacologia 44:257–262
Gurwitz D, Egozi Y, Henis YI, Kloog Y, Sokolovsky M (1987) Agonist and antagonist binding to rat brain muscarinic receptors: influence of aging. Neurobiol Aging 8:115–122
Hermann BP, Wyler A, Steenman H, Richey E (1988) The interrelationship between language function and verbal learning/memory performance in patients with complex partial seizures. Cortex 24:245–253
Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier RG, Luthra SK, Brooks DJ, Lammertsma AA (1992) Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12:47–54
Ikeda Y, Ooshiro K, Tomoda Y, Fujiki Y, Okuyama S, Itoh T, Yamauchi T (1989) Aging-induced memory deficit indicated by newly-developed memory test. Proceedings of the Fourth Congress of the International Psychogeriatric Association (abstract) p 120
Inoue O, Tsukada H, Yonezawa H, Suhara T, Långström B (1991a) Reserpine-induced reduction of in vivo binding of SCH23390 andN-methylspiperone and its reversal byd-amphetamine. Eur J Pharmacol 197:143–149
Inoue O, Kobayashi K, Tsukada H, Itoh T, Långström B (1991b) Difference in in vivo receptor binding between [3H]N-methylspiperone and [3H]raclopride in reserpine-treated mouse brain. J Neural Transm 85:1–10
Inoue O, Kobayashi K, Suhara T (1992) Effect of sedative drugs upon receptor binding in vivo. Prog Neuropsychopharmacol Biol Psychiatry 16:783–789
King DJ (1992) Benzodiazepines, amnesia and sedation: theoretical and clinical issues and controversies. Hum Psychopharmacol 7:79–87
Koeppe RA, Frey KA, Zubieta JA, Fessler JA, Mulholland GK, Kilbourn MR, Mangner TJ, Kuhl DE (1992) Tracer kinetic analysis of [C-11]N-methyl-4-piperidyl benzilate binding to muscarinic cholinergic receptors. J Nucl Med 33:882
Lin S-C, Olson KC, Okazaki H, Richelson E (1986) Studies on muscarinic binding site in human brain identified with [3H]pirenzepine. J Neurochem 46:274–279
Lister RG (1985) The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev 9:87–94
Mathew RJ, Wilson WH, Daniel DG (1985) The effect of nonsedating dose of diazepam on regional cerebral blood flow. Biol Psychiatry 20:1109–1116
Matthew E, Pettigrew K, Andreason P, Cohen R, Carson R, Herscovitch P, King C, Paul SM (1991) Receptor-mediated benzodiazepine effects on regional cerebral blood flow. J Cereb Blood Flow Metab 11:S277
Matui T, Hirano A (1977) An atlas of the human brain for computerized tomography. Igaku Shoin, Tokyo
Morris HH, Estes ML (1987) Traveler's amnesia: transient global amnesia secondary to triazolam. JAMA 258:945–946
Mulholland GK, Jewett DW, Otto CA, Kilbourn MR, Sherman PS, Kuhl DE (1988) Synthesis and regional brain distribution of [C-11]N-methyl-4-piperidyl benzilate ([C-11]NMPB) in the rat. J Nucl Med 29:768
Nabeshima T, Tohyama K, Ichihara K, Kameyama T (1990) Effects of benzodiazepine on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and cholinergic neural system. J Pharmacol Exp Ther 255:789–794
Nilvebrant L, Sparf B (1986) Dicyclamine, benzenol and ocybutynine distinguish between subclasses of muscarinic binding sites. Eur J Pharmacol 123:133–143
Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS (1981) Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 22:81–110
Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5:584–590
Petkov V, Georgiev VP, Getova D, Petkov VV (1982) Effects of some benzodiazepines on the acetylcholine release in the anterior horn of the lateral cerebral ventricle of the cat. Acta Physiol Pharmacol Bulg 8:59–65
Petkov V, Georgiev V, Getova D, Petkov VV (1983) On the effects of diazepam, hyoscine and oxotremorine on acetylcholine release from the cerebral cortex. Acta Physiol Pharmacol Bulg 9:3–12
Ross SB, Jackson DM (1989) Kinetic properties of the accumulation of3H-raclopride in the mouse brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 340:6–12
Roth T, Hartse KM, Saab PG, Piccione PM, Kramer M (1980) The effects of flurazepam, lorazepam, and triazolam on sleep and memory. Psychopharmacology 70:231–237
Sarter M, Bruno JP, Dudchenko (1990) Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification. Psychopharmacology 101:1–17
Scharf MB, Fletcher K, Graham JP (1988) Comparative amnesic effects of benzodiazepine hypnotic agents. J Clin Psychiatry 49:134–137
Sethy VH (1978) Effect of hypnotic and anxiolytic agents on regional concentration of acetylcholine in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 301:157–161
Sitaram N, Weingartner H, Gillin JC (1978) Human serial learning: enhancement with arecholine and impairment with scopolamine. Science 201:274–276
Sokolovsky M, Egozi Y, Kloog Y (1980) Biochemical characterization of muscarinic receptors, Monogr Neural Sci 7:30–40
Suhara T, Inoue O, Kobayasi K (1990) Effect of desipramine on dopamine receptor binding in vivo. Life Sci 47:2119–2126
Suhara T, Nakayama K, Inoue O, Fukuda H, Shimizu M, Mori A, Tateno Y (1992) D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology 106:14–18
Suhara T, Inoue O, Kobayashi K, Suzuki K, Tateno Y (1993) Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography. Neurosci Lett 149:225–228
Weingartner HJ, Hommer D, Lister RG, Thompson K, Wolkowitz O (1992) Selective effects of triazolam on memory. Psychopharmacology 106:341–345
Wong DF, Wagner HN Jr, Dannals RF, Links JM, Frost JJ, Ravert HT, Wilson AA, Rosenbaum AE, Gjedde A, Douglass KH, Petronis JD, Folstein MF, Toung JKT, Burns HD, Kuhar MJ (1984) Effects of age on dopamine and serotonin receptors measured by positron tomography in living human brain. Science 226:1393–1396
Wong DF, Gjedde A, Wagner HN Jr (1986) Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands. J Cereb Blood Flow Metab 6:137–146
Young LT, Wong DF, Goldman S, Minkin E, Chen C, Matsumura K, Scheffel U, Wagner HN Jr (1991) Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain. Synapse 9:188–194
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suhara, T., Inoue, O., Kobayashi, K. et al. An acute effect of triazolam on muscarinic cholinergic receptor binding in the human brain measured by positron emission tomography. Psychopharmacology 113, 311–317 (1994). https://doi.org/10.1007/BF02245202
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245202